+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Deuterated Building Blocks 38385-95-4
38385-95-4,MFCD01475843
Catalog No.:AA0032S4

38385-95-4 | 2-Piperidin-4-yl-1h-benzoimidazole

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
95%
in stock  
$13.00   $9.00
- +
5g
95%
in stock  
$39.00   $27.00
- +
100g
95%
in stock  
$708.00   $496.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA0032S4
Chemical Name:
2-Piperidin-4-yl-1h-benzoimidazole
CAS Number:
38385-95-4
Molecular Formula:
C12H15N3
Molecular Weight:
201.2676
MDL Number:
MFCD01475843
SMILES:
N1CCC(CC1)c1nc2c([nH]1)cccc2
Properties
Properties
 
BP:
441.3°C at 760 mmHg  
Form:
Solid  
MP:
>245ºC (dec.)  
Storage:
Inert atmosphere;Room Temperature;  

Computed Properties
 
Complexity:
213  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
1  
XLogP3:
1.9  

Upstream Synthesis Route

[1]Patent:US6660751,2003,B1,.Locationinpatent:Pagecolumn7,8

[2]BioorganicandMedicinalChemistryLetters,2004,vol.14,#3,p.695-699

[3]JournalofHeterocyclicChemistry,1995,vol.32,#3,p.707-718

[4]JournalofHeterocyclicChemistry,1989,vol.26,p.541-543

[5]Patent:WO2010/80357,2010,A1,.Locationinpatent:Page/Pagecolumn41-42

[6]JournalofMedicinalChemistry,2014,vol.57,#12,p.5435-5448

[7]Patent:WO2011/143444,2011,A2,.Locationinpatent:Page/Pagecolumn7;87-90

[8]MedicinalChemistryResearch,2011,vol.20,#5,p.558-565

[9]ChemicalBiologyandDrugDesign,2015,vol.86,#4,p.509-516

[10]Patent:WO2018/42305,2018,A1,.Locationinpatent:Page/Pagecolumn15;16

[1]BioorganicandMedicinalChemistryLetters,2009,vol.19,#8,p.2206-2210

[1]Patent:US2005/101587,2005,A9,

[1]SyntheticCommunications,2011,vol.41,#9,p.1394-1402

[2]ChemicalBiologyandDrugDesign,2015,vol.86,#4,p.509-516

Downstream Synthesis Route

[1]Patent:US6660751,2003,B1.Locationinpatent:Pagecolumn7,8

[2]BioorganicandMedicinalChemistryLetters,2004,vol.14,p.695-699

[3]JournalofHeterocyclicChemistry,1995,vol.32,p.707-718

[4]JournalofHeterocyclicChemistry,1989,vol.26,p.541-543

[5]Patent:WO2010/80357,2010,A1.Locationinpatent:Page/Pagecolumn41-42

[6]JournalofMedicinalChemistry,2014,vol.57,p.5435-5448

[7]Patent:WO2011/143444,2011,A2.Locationinpatent:Page/Pagecolumn7;87-90

[8]MedicinalChemistryResearch,2011,vol.20,p.558-565

[9]ChemicalBiologyandDrugDesign,2015,vol.86,p.509-516

[10]Patent:WO2018/42305,2018,A1.Locationinpatent:Page/Pagecolumn15;16

[11]Patent:US10501421,2019,B1.Locationinpatent:Page/Pagecolumn121-122

[1]Patent:US2005/101587,2005,A9

[1]Patent:US2005/101587,2005,A9

38385-95-4   
2-(1-{4-3-phenyl-5-(1<i>H</i>-tetrazol-5-yl)-pyridin-2-yl-benzyl}-piperidin-4-yl)-1<i>H</i>-benzoimidazole 

[1]BioorganicandMedicinalChemistryLetters,2005,vol.15,p.905-909

38385-95-4   
2-1-(4-Fluoro-benzyl)-piperidin-4-yl-1-methyl-1H-benzoimidazole 

[1]JournalofHeterocyclicChemistry,1995,vol.32,p.707-718

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 38385-95-4
824403-74-9

824403-74-9

 295790-48-6

295790-48-6

 295790-49-7

295790-49-7

 1241675-83-1

1241675-83-1

 42784-26-9

42784-26-9

 64137-52-6

64137-52-6
Building Blocks
More >
Tags:38385-95-4 Molecular Formula|38385-95-4 MDL|38385-95-4 SMILES|38385-95-4 2-Piperidin-4-yl-1h-benzoimidazole